You are here

You are here

AKU study to test if hydroxychloroquine can prevent spread of Covid-19 among frontline healthcare staff

29 October 2020

As the world waits impatiently for a Covid-19 vaccine, a new study to test if hydroxychloroquine or chloroquine can prevent the coronavirus in vital healthcare workers has begun enrolling participants at the Aga Khan University (AKU) in Karachi. The AKU is the first centre outside of the UK to be participating in the study led by the University of Oxford in the UK. The study, COPCOV, will see half of participants given hydroxychloroquine or chloroquine, while the other half will receive a placebo.